| Ytd | 123.59% | |
| 1y | 68.13% |
| Open | 32.24 | Prev Close | 31.98 | Low | 31.28 | High | 33.18 | Mkt Cap | 9.92B |
| Vol | 9.46M | Avg Vol | 5.42M | EPS | 1.30 | P/E | 24.72 | Forward P/E | 14.83 |
| Beta | 2.37 | Short Ratio | 2.87 | Inst. Own | 73.81% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-09 | 50-d Avg | 30.71 | 200-d Avg | 21.17 | 1yr Est | 34.60 |
Oscar Health, Inc. (âOscar Healthâ or the âCompanyâ) (NYSE: OSCR) announced that on Septembe
NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar Health” or the “Company”) (NYSE: OSCR) announc
Oscar Health (OSCR) could be a great choice for investors looking to buy stocks that have gained str
Raymond James analyst John Ransom maintains Oscar Health (NYSE:OSCR) with a Outperform and raises
B of A Securities analyst Adam Ron maintains Oscar Health (NYSE:OSCR) with a Underperform and rai
Shares of Oscar Health Inc. (NYSE:OSCR) are trading higher Thursday morning as Wall Street analysts
Shares of Oscar Health are trading higher Thursday as Wall Street analysts raised price targets foll
Stephens & Co. analyst Raj Kumar reiterates Oscar Health (NYSE:OSCR) with a Equal-Weight and
Barclays analyst Andrew Mok maintains Oscar Health (NYSE:OSCR) with a Overweight and raises the p
Baird analyst Michael Ha maintains Oscar Health (NYSE:OSCR) with a Neutral and raises the price t
WOOF, ARW and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 17th, 2
Tidal Investments LLC bought a new stake in Oscar Health, Inc. (NYSE: OSCR) in the undefined quarter
Oscar Health, Inc. (OSCR) Analyst/Investor Day Transcript
Centene's diversified market presence, cash generation and recent share gains give it an edge over O
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
The insurer's grab for share in a shrinking ACA market looks like a winner — for now.
As previously announced, Oscar Health, Inc. (the "Company" or "Oscar") will host its
Oscar Health, Inc. (OSCR) closed at $32.62 in the latest trading session, marking a -3.53% move from
VLO, SNDR and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 15th, 2
Here is how Oscar Health, Inc. (OSCR) and Amerant Bancorp Inc. (AMTB) have performed compared to the
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
After reaching an important support level, Oscar Health, Inc. (OSCR) could be a good stock pick from
Oscar Health, Inc. (OSCR) is looking like an interesting pick from a technical perspective, as the c
BMA, ATI, and OSCR it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 4, 2026.
Oscar Health's membership jumps 46% to 2.96 million, but seasonal enrollment and medical utilization
OSCR, LQDT and GEO made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 2, 20
LCUT, CURI, OSCR, CTOS and CHYM have been added to the Zacks Rank #1 (Strong Buy) List on September
Oscar Health has surged 109% YTD as membership, revenue and expansion plans strengthen, though its p
SNDR, NESR and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 28th, 202
Wells Fargo analyst Stephen Baxter maintains Oscar Health (NYSE:OSCR) with a Equal-Weight and rai
UBS analyst Jonathan Yong maintains Oscar Health (NYSE:OSCR) with a Neutral and raises the price
Barclays analyst Andrew Mok maintains Oscar Health (NYSE:OSCR) with a Overweight and raises the p
Oscar Health (OSCR) beat Q2 earnings with $4.88B revenue, but shares fell on expected ACA membership
Oscar Health (NYSE:OSCR) affirms FY2026 sales outlook from $18.700 billion-$19.000 billion to $18.70
As of June 30, Effectuated Membership by Offering2026 2025 Individual and Small Group (1)2,963,
Oscar Health (NYSE:OSCR) reported quarterly earnings of $1.10 per share which beat the analyst conse
Elevance Health (ELV) beats Q2 expectations but triggers a broader managed-care selloff after a cons
Barclays analyst Andrew Mok upgrades Oscar Health (NYSE:OSCR) from Equal-Weight to Overweight and
Oscar Health shares reach fresh 52-week highs Wednesday, extending an 80% YTD rally after Monday'
Oscar Health shares surged after the company reaffirmed its 2026 outlook and provided a business upd
Stocks had mixed performance on Thursday, Dow Jones up 793 points while Nasdaq down 232 points. Rumb
UBS analyst Jonathan Yong maintains Oscar Health (NYSE:OSCR) with a Neutral and raises the price
Barclays analyst Andrew Mok maintains Oscar Health (NYSE:OSCR) with a Equal-Weight and raises the
Baird analyst Michael Ha maintains Oscar Health (NYSE:OSCR) with a Neutral and raises the price t
Wall Street analysts changed outlook on top names. Check out analyst rating changes, including upgra
Oscar Health (NYSE:OSCR) affirms FY2026 sales outlook from $18.700 billion-$19.000 billion to $18.70